PLG-101

N/A

Report date: 2025/01/26 16:10:12

Base Information

Drug NamePLG-101
Drug Alias NameVEGFR receptor antagonist (PhiloGene)VEGF-1/VEGF-2 receptor antagonist (PhiloGene)PLG-101
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsVascular endothelial growth factor receptor 1 antagonists
TargetsVascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 2
Therapy Area/IndicationsMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhiloGene Inc
China Registration ClassN/A

Develop Information

Active CompaniesPhiloGene Inc
Inactive CompaniesN/A
Active IndicationsMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A